Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Tamara FountainDirector | RxSightRXST | Open-market sale10b5-1 plan | 25/03/12 | 25/03/13 | 7,000 sh | $25.71 | $179,970 | −22.0% |
Maniar ShwetaDirector | RxSightRXST | Open-market sale10b5-1 plan | 25/01/22 | 25/01/27 | 3,519 sh | $30.87 | $108,631.53 | −32.3% |
RxSightRXST | Open-market buy | 25/01/15–25/01/16 | 25/01/17 | 3,210 sh2 trades | $31.16avg. | $100,013.88 | No record | |
Ilya GoldshlegerSEE REMARKS | RxSightRXST | Open-market sale10b5-1 plan | 24/11/29 | 24/12/03 | 3,105 sh | $46.08 | $143,078.4 | −6.8% |
Maniar ShwetaDirector | RxSightRXST | Open-market sale10b5-1 plan | 24/11/26 | 24/11/26 | 3,782 sh | $45.88 | $173,518.16 | −25.8% |
RxSightRXST | Open-market sale10b5-1 plan | 24/11/22–24/11/26 | 24/11/26 | 6,200 sh2 trades | $45.44avg. | $281,728 | −12.8% | |
RxSightRXST | Open-market sale10b5-1 plan | 24/11/15–24/11/18 | 24/11/18 | 7,975 sh3 trades | $45.61avg. | $363,752.31 | −15.9% | |
RxSightRXST | Open-market buy | 24/11/12–24/11/13 | 24/11/14 | 22,476 sh4 trades | $45.14avg. | $1,014,596.77 | No record | |
Ilya GoldshlegerSEE REMARKS | RxSightRXST | Open-market sale10b5-1 plan | 24/11/12 | 24/11/14 | 1,330 sh | $46.13 | $61,352.9 | −3.1% |
RxSightRXST | Open-market sale10b5-1 plan | 24/11/07 | 24/11/08 | 3,100 sh2 trades | $55.00avg. | $170,490 | −6.8% | |
RxSightRXST | Open-market sale10b5-1 plan | 24/11/04 | 24/11/05 | 3,100 sh2 trades | $51.04avg. | $158,235.6 | −6.8% | |
Ilya GoldshlegerSEE REMARKS | RxSightRXST | Open-market sale10b5-1 plan | 24/10/30 | 24/10/31 | 3,105 sh | $51.91 | $161,180.55 | −6.8% |
RxSightRXST | Open-market sale10b5-1 plan | 24/10/25–24/10/28 | 24/10/28 | 6,200 sh2 trades | $50.22avg. | $311,333 | −12.8% | |
Ilya GoldshlegerSEE REMARKS | RxSightRXST | Open-market sale10b5-1 plan | 24/10/22 | 24/10/22 | 3,100 sh | $49.68 | $154,008 | −6.8% |
RxSightRXST | Open-market sale10b5-1 plan | 24/10/16–24/10/18 | 24/10/18 | 6,205 sh4 trades | $49.93avg. | $309,837.53 | −12.8% | |
RxSightRXST | Open-market sale10b5-1 plan | 24/10/10–24/10/14 | 24/10/15 | 9,305 sh3 trades | $49.70avg. | $462,454.1 | −18.1% | |
RxSightRXST | Open-market sale10b5-1 plan | 24/10/04–24/10/08 | 24/10/08 | 6,200 sh4 trades | $48.14avg. | $298,438.42 | −12.8% | |
RxSightRXST | Open-market sale10b5-1 plan | 24/10/01 | 24/10/02 | 15,000 sh3 trades | $48.45avg. | $726,764.55 | −33.0% | |
RxSightRXST | Open-market sale10b5-1 plan | 24/09/26–24/09/30 | 24/09/30 | 6,205 sh3 trades | $49.15avg. | $304,983.57 | −12.8% | |
RxSightRXST | Open-market sale10b5-1 plan | 24/09/20–24/09/23 | 24/09/23 | 6,200 sh3 trades | $52.93avg. | $328,147.5 | −12.8% |